Next-Gen Neurotechnologies: Graphene Electrodes and Magnetic Surgical Robotics in Deep Brain Neuromodulation
Dr. Dereck Mush, MD, MBA
NeuroPace
Manufacturing responsive neurostimulation systems for the treatment of refractory epilepsy.
What they do
The company produces an implantable, closed-loop neurostimulation system that monitors brain activity continuously. When the device detects abnormal brain patterns that precede a seizure, it delivers small electrical pulses to prevent the seizure before symptoms begin.
The record
- Vertical
- Neurotech
- Sub-segment
- Neuromodulation
- Product type
- Device
- Stage
- Public
- Headquarters
- Mountain View, USA
- Region
- North America
- Founded
- 1997
- Total funding
- $220M raised
Notable investors: KPCB, New Enterprise Associates, OrbiMed.
Also in Neurotech
Related on The Signal
Dr. Dereck Mush, MD, MBA